Saturday, February 25, 2023
8:15 PM – 8:30 PM CST: Registration & Dinner
8:30 PM – 9:30 PM CST: Symposium
Grand Hyatt San Antonio River Walk
600 East Market Street
San Antonio, TX 78205
Meeting room: Texas Ballroom C, Fourth Floor
PROGRAM FEATURES
- Interactive, case-based learning environment
- Simulation challenge animations
- Create your own personalized poster
FACULTY
Diego J. Maselli, MD, FCCP
Associate Professor of Medicine
Interim Chief, Division of Pulmonary Diseases & Critical Care
UT Health at San Antonio
Director, Respiratory Care, University Health System
Director, Severe Asthma Program, University Health System
San Antonio, TX
Michael Wechsler, MD, MMSc
Professor of Medicine – National Jewish Health
Director, National Jewish Cohen Family Asthma Institute
Denver, CO
TARGET AUDIENCE
This activity is designed to meet the educational needs of allergists, immunologists, and other health care providers involved in the care of patients with moderate-to-severe asthma.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Identify evidence-based strategies for treatment regimen selection or adjustments based on patient-centered factors and clinical presentation
- Describe strategies for patient-centered communication, education, and shared decision making to potentially reduce the occurrence of low adherence to treatment
- Discuss the clinical evidence for recently approved and investigational agents for the potential treatment of moderate to severe asthma
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]. Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
